Current diagnostic approaches to invasive candidiasis in critical care settings.
For the specialist, the management of invasive candidiasis infections, from diagnosis to selection of the therapeutic protocol, is often a challenge. Although early diagnosis and treatment are associated with a better prognosis, apart from cases with positive blood cultures or fluid/tissue biopsy, diagnosis is neither sensitive nor specific, relying on many different factors, clinical and laboratory findings but there is certainly a need for the specific markers in this disease. Recently, new serodiagnostic assays as Candida albicans germ-tube antibodies or (1,3)-beta-D-glucan detection and molecular techniques for the detection of fungal-specific DNA have been developed with controversial results in critical care setting. One of the main features in diagnosis is the evaluation of risk factor for infection, which will identify patients in need of preemptive or empirical treatment. Clinical scores were built from those risk factors. For these reasons, an approach to the new diagnosis tools in the clinical mycology laboratory and an analysis of the new prediction rules and its application situations has been made. Currently, the combination of prediction rules and non-culture microbiological tools could be the clue for improving the diagnosis and prognosis of invasive fungal infections in critically ill patients.
Pemán
Javier
J
Servicio de Microbiología, Hospital Universitario La Fe, Valencia, Spain. peman_jav@gva.es
Zaragoza
Rafael
R
D000908:Antibodies, Fungal / Q000097:blood; D002175:Candida / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D058387:Candidemia / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D058365:Candidiasis, Invasive / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D003422:Critical Care; D004271:DNA, Fungal / Q000032:analysis; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods; D011237:Predictive Value of Tests; D012307:Risk Factors
D000908:Antibodies, Fungal; D004271:DNA, Fungal